In line with these findings, it was recently shown that activating mutations in CARD11 (observed in ~5% of DLBCL (ref. 5)), a NF-κB activator protein downstream BCR signaling, increases GC formation and GC B-cell proliferation through enhanced cycling64. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.